Niranjan Kanesa-Thasan

Niranjan Kanesa-thasan, M.D., MTMH, FIDSA, FASTMH is the Chief Medical Officer (CMO) of Icosavax and is a global medical executive with a successful 25-year career in vaccine research and development leading to seven licensed vaccines. He has extensive leadership and management experience in the biopharmaceutical industry (vice president, GSK Vaccines and Novartis Vaccines; Acambis, acquired by Sanofi Pasteur), government (Walter Reed Army Institute for Research, US Army Medical Research Institute for Infectious Diseases), and academia (Uniformed Services University of the Health Sciences, University Hospitals of Cleveland). His special expertise is in emerging infectious diseases and virus vaccines. Niranjan received an M.D. from the Johns Hopkins School of Medicine, a Masters in Tropical Medicine and Hygiene (MTMH) from the Uniformed Services University of the Health Sciences, and a B.A. from Johns Hopkins University. He completed residency training and chief residency in pediatrics and a fellowship in pediatric infectious disease and geographic medicine.